1-(3-{[5-(2-chlorophenoxymethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}propyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one

Catalog No. :
ACNOMG586
CAS No. :
949847-41-0
Molecular Formula :
C19H17ClN4O3S
Molecular Weight :
416.89

IUPAC Name:1-(3-((5-((2-chlorophenoxy)methyl)-1,3,4-oxadiazol-2-yl)thio)propyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one

1-(3-{[5-(2-chlorophenoxymethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}propyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$466.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-{[5-(2-chlorophenoxymethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}propyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one
IUPAC Name1-(3-((5-((2-chlorophenoxy)methyl)-1,3,4-oxadiazol-2-yl)thio)propyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one
MDL No.-
Molecular FormulaC19H17ClN4O3S
Molecular Weight416.89
SMILESO=C1N(CCCSC2=NN=C(COC3=CC=CC=C3Cl)O2)C4=CC=CC=C4N1
InChI KeyPUUIAVCGIHGDQE-UHFFFAOYSA-N
Synonym1-(3-{[5-(2-chlorophenoxymethyl)-1,3,4-oxadiazol-2-yl]sulfanyl}propyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one;2H-Benzimidazol-2-one, 1-[3-[[5-[(2-chlorophenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]propyl]-1,3-dihydro-
CAS No.949847-41-0

Synthetic Route by SureRoute

1. ACNOMG586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACISKE162 route compound structure diagram
    ACISKE16262780-89-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNOMG586 route product structure diagram
    ACNOMG586949847-41-0
Inquiry

2. ACNOMG586 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNOMG586 route product structure diagram
    ACNOMG586949847-41-0
Inquiry

Comments (0)